Hopitaux universitaires de Strasbourg, Bordeaux, France.
BJU Int. 2014 May;113(5b):E56-61. doi: 10.1111/bju.12397. Epub 2013 Oct 31.
To assess the use of local haemostatic agents (HAs) in a prospective multicentre large series of partial nephrectomies (PNs).
Prospective National Observational Registry on the Practices of Haemostasis in Partial Nephrectomy (NEPHRON): the study was conducted in 54 French urological centres from 1 June to 31 December 2010. In all, 570 consecutive patients undergoing a PN were enrolled in this study in a prospective manner. The data was collected prospectively via an electronic case-report form: five different sheets were included for preoperative, perioperative, postoperative and follow-up data respectively. Information related to haemostasis was analysed.
The median patient age was 60 years and the mean (range) tumour size was 3.68 (0.19-15) cm. An HA was primarily used in 71.4% of patients, with a statistically significant difference among surgical approaches (P = 0.024). In 91.8% of cases, a single use of a HA was sufficient for achieving haemostasis. The HA was used either alone (13.9%) or in association with sutures (80.3%). One or more additional haemostatic action(s) was needed in 12.3% of the cases. When comparing patients who received a HA with those who did not receive a HA, there was no statistical difference between the groups for tumour size (P = 0.542), collecting system drainage (P = 0.538), hospital stay (P = 0.508), operation time (P = 0.169), blood loss (P = 0.387) or transfusion rate (P = 0.713).
HAs are widely used by urologists during PN. Progress is needed for standardising HA application, especially for the timing of application. For the time being, the role of the HA in nephron-sparing surgery is still to be evaluated.
评估局部止血剂(HA)在一项大型前瞻性多中心部分肾切除术(PN)系列研究中的应用。
前瞻性全国 PN 止血实践观察登记研究(NEPHRON):该研究于 2010 年 6 月 1 日至 12 月 31 日在法国 54 个泌尿外科中心进行。共前瞻性纳入 570 例连续接受 PN 的患者。通过电子病例报告表系统采集数据:分别包括术前、围手术期、术后和随访的 5 份不同表格。分析与止血相关的数据。
患者的中位年龄为 60 岁,平均(范围)肿瘤大小为 3.68(0.19-15)cm。71.4%的患者主要使用了 HA,不同手术方法之间存在统计学显著差异(P = 0.024)。91.8%的病例中,单一使用 HA 即可实现止血。HA 单独使用(13.9%)或与缝线联合使用(80.3%)。12.3%的病例需要进行 1 次或更多次附加止血操作。与未使用 HA 的患者相比,使用 HA 的患者在肿瘤大小(P = 0.542)、收集系统引流(P = 0.538)、住院时间(P = 0.508)、手术时间(P = 0.169)、出血量(P = 0.387)或输血率(P = 0.713)方面均无统计学差异。
HA 在 PN 中被泌尿科医生广泛使用。需要进一步规范 HA 的应用,特别是应用时机。目前,HA 在保肾手术中的作用仍有待评估。